ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
122 hedge funds and large institutions have $532M invested in Array Biopharma Inc in 2014 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 41 increasing their positions, 42 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
66% less call options, than puts
Call options by funds: $1.61M | Put options by funds: $4.79M
76% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 25
Holders
122
Holding in Top 10
4
Calls
$1.61M
Puts
$4.79M
Top Buyers
| 1 | +$4.57M | |
| 2 | +$4.56M | |
| 3 | +$4.39M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$4.08M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.85M |
Top Sellers
| 1 | -$2.59M | |
| 2 | -$2.52M | |
| 3 | -$2.42M | |
| 4 |
Renaissance Technologies
New York
|
-$1.82M |
| 5 |
QF
QVT Financial
New York
|
-$1.77M |